TCPGdb: A Comprehensive T-cell Perturbation Genomics Database for the Identification of Critical T-cell Regulators
Large parallel genetic screens have been used to identify targets and regulators that enhance T-cell antitumor capability and persistence in the tumor microenvironment. We hypothesized that by combining the pooled screen data from multiple independent genetic screens, we could provide a systematic, comprehensive, and robust analysis of the effect of gene perturbation on T cell-based immunotherapies. After collecting data from previously published T-cell screens, including CRISPR-based and open reading frame-based screens, through the Gene Expression Omnibus, we reprocessed the gene hits summary and conducted a pathway enrichment analysis. A T-cell screen perturbation score metric was employed to quantify the impact of a gene perturbation on T-cell function. Additionally, gene expression data (both bulk RNA level and single-cell RNA level) from autoimmune disease cohorts and patients with T cell-derived cancer were incorporated to gain further insight into gene perturbations that potentially augment T-cell proliferation. We integrated all data and analysis on 35 T-cell screens into our state-of-the-art T-cell perturbation genomics database (TCPGdb), which is accessible through our web server (http://tcpgdb.sidichenlab.org/) and allows users to interactively explore the impact of query genes on T-cell function.
Authors
- Chuanpeng Dong (ORCID: https://orcid.org/0000-0001-5068-0495)
- Nipun Verma (ORCID: https://orcid.org/0000-0002-9522-6699)
- Feifei Zhang (ORCID: https://orcid.org/0000-0001-9330-9338)
- Hongyu Zhao (ORCID: https://orcid.org/0000-0003-1195-9607)
- Sidi Chen (ORCID: https://orcid.org/0000-0002-3819-5005)
- Di Feng (ORCID: https://orcid.org/0000-0002-0964-9995)
- Xinxin Zhu (ORCID: https://orcid.org/0000-0002-5673-9977)
- J. Cai (ORCID: https://orcid.org/0000-0002-4945-6733)
- Kaiyuan Tang (ORCID: https://orcid.org/0009-0006-4538-6519)
Institutions
- Yale Cancer Center (US)
- Yale University (US)
- Boehringer Ingelheim (Brazil) (BR)
- Yale New Haven Health System (US)
- Boehringer Ingelheim (Egypt) (EG)
- Boehringer Ingelheim (France) (FR)
- Boehringer Ingelheim (United States) (US)
- Boehringer Ingelheim (Spain) (ES)
- Texas A&M University (US)
Publication Details
- Journal
- Cancer Immunology Research
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1158/2326-6066.cir-25-0168
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 0.00